229 related articles for article (PubMed ID: 24720082)
1. Basal cell carcinoma.
Gupta AK; Daigle D; Martin G
Skinmed; 2014; 12(1):33-8; quiz 38. PubMed ID: 24720082
[TBL] [Abstract][Full Text] [Related]
2. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
3. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
Dessinioti C; Plaka M; Stratigos AJ
Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma: a paradigm for targeted therapies.
Dreier J; Felderer L; Barysch M; Rozati S; Dummer R
Expert Opin Pharmacother; 2013 Jul; 14(10):1307-18. PubMed ID: 23656611
[TBL] [Abstract][Full Text] [Related]
5. Advanced basal cell carcinoma.
Wollina U; Tchernev G
Wien Med Wochenschr; 2013 Aug; 163(15-16):347-53. PubMed ID: 23589318
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic treatment options for advanced epithelial skin cancer.
Soura E; Chasapi V; Stratigos AJ
Expert Opin Pharmacother; 2015; 16(10):1479-93. PubMed ID: 26027692
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer.
Ganti AK; Kessinger A
Cancer Treat Rev; 2011 Oct; 37(6):440-3. PubMed ID: 21216106
[TBL] [Abstract][Full Text] [Related]
8. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
Sobanko JF; Okman J; Miller C
J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
[TBL] [Abstract][Full Text] [Related]
9. Topical and systemic medical treatments of basal cell carcinoma.
Sollena P; Del Regno L; Fargnoli MC; Peris K
G Ital Dermatol Venereol; 2015 Aug; 150(4):429-34. PubMed ID: 26086413
[TBL] [Abstract][Full Text] [Related]
10. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
[TBL] [Abstract][Full Text] [Related]
11. Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature.
Gropper AB; Girouard SD; Hojman LP; Huang SJ; Qian X; Murphy GF; Vleugels RA
J Cutan Pathol; 2012 May; 39(5):526-34. PubMed ID: 22515224
[TBL] [Abstract][Full Text] [Related]
12. Current landscape for treatment of advanced basal cell carcinoma.
Foley P
Australas J Dermatol; 2015 Mar; 56 Suppl 1():1-7. PubMed ID: 25715811
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma - molecular biology and potential new therapies.
Kasper M; Jaks V; Hohl D; Toftgård R
J Clin Invest; 2012 Feb; 122(2):455-63. PubMed ID: 22293184
[TBL] [Abstract][Full Text] [Related]
15. Assessing current treatment options for patients with severe/advanced basal cell carcinoma.
Weinstock MA; Still JM
Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S10-3. PubMed ID: 22177101
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of basal cell carcinoma].
Schmitz L; Dirschka T
Hautarzt; 2016 Jun; 67(6):483-99. PubMed ID: 27206448
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.
Bakshi A; Chaudhary SC; Rana M; Elmets CA; Athar M
Mol Carcinog; 2017 Dec; 56(12):2543-2557. PubMed ID: 28574612
[TBL] [Abstract][Full Text] [Related]
18. Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus.
Peris K; Licitra L; Ascierto PA; Corvò R; Simonacci M; Picciotto F; Gualdi G; Pellacani G; Santoro A
Future Oncol; 2015; 11(4):703-12. PubMed ID: 25686123
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary management of advanced basal cell carcinoma: report of four cases.
Yu J; Aldabagh B; Wang J; Yom SS; El-Sayed I; Knott D; McGrath MH; Arron S;
J Drugs Dermatol; 2014 May; 13(5):601-6. PubMed ID: 24809887
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
Kudchadkar R; Lewis K; Gonzalez R
Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
